Estée Lauder and Puig Confirm Merger Talks

March 24. Estée Lauder Companies and Puig confirmed they are in merger discussions. The announcement came Monday, no timeline given, no structure disclosed.

Estée Lauder holds MAC, Clinique, Tom Ford Beauty, Le Labo, and Frederic Malle. Puig owns Byredo, Rabanne, Charlotte Tilbury, Dries Van Noten fragrance, and recently acquired a stake in Issey Miyake perfumes. Combined revenue would push the entity past $30 billion, second only to L'Oréal in the beauty-conglomerate rankings.

The structure matters here. Puig is still family-controlled, third generation, Marc Puig as chairman. Estée Lauder is publicly traded but Lauder family-majority-owned, with William Lauder as executive chairman. A merger of this scale would require navigating two family architectures and two regulatory environments. The Spanish Competition Authority and the U.S. Federal Trade Commission both get to weigh in.

What the deal suggests: neither house is confident it can scale alone at the speed the market now demands. Estée Lauder has struggled in Asia, particularly China, where local brands and K-beauty have eroded its prestige position. Puig has distribution strength in Europe and Latin America but lacks the North American retail footprint Estée Lauder commands. The fit is geographic, not redundant.

The brand overlap is minimal. Estée Lauder skews heritage-prestige and niche-fragrance. Puig skews contemporary-cool and indie-turned-luxury. Byredo does not compete with Le Labo in register; Charlotte Tilbury does not compete with MAC in channel. The portfolio post-merger would cover more aesthetic ground than any current conglomerate except L'Oréal.

Both houses declined to comment beyond the confirmation. No closing date, no equity split, no leadership structure announced. The filing says discussions are ongoing. That means this could close in Q3 or fall apart in June. Watch the Trade Commission calendar.